These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
282 related articles for article (PubMed ID: 29730261)
21. pH-sensitive and tumor-targeting nanogels based on ortho ester-modified PEG for improving the in vivo anti-tumor efficiency of doxorubicin. Wang X; Zheng Y; Xue Y; Wu Y; Liu Y; Cheng X; Tang R Colloids Surf B Biointerfaces; 2021 Nov; 207():112024. PubMed ID: 34384973 [TBL] [Abstract][Full Text] [Related]
22. Ligand-directed stearic acid grafted chitosan micelles to increase therapeutic efficacy in hepatic cancer. Yang Y; Yuan SX; Zhao LH; Wang C; Ni JS; Wang ZG; Lin C; Wu MC; Zhou WP Mol Pharm; 2015 Feb; 12(2):644-52. PubMed ID: 25495890 [TBL] [Abstract][Full Text] [Related]
23. Exogenous vitamin C triggered structural changes of redox-activated dual core-crosslinked biodegradable nanogels for boosting the antitumor efficiency. Zhu Y; He Y; Su T; Li C; Cai S; Wu Z; Huang D; Zhang X; Cao J; He B J Mater Chem B; 2020 Jun; 8(23):5109-5116. PubMed ID: 32412025 [TBL] [Abstract][Full Text] [Related]
24. Galactose-modified selenium nanoparticles for targeted delivery of doxorubicin to hepatocellular carcinoma. Xia Y; Zhong J; Zhao M; Tang Y; Han N; Hua L; Xu T; Wang C; Zhu B Drug Deliv; 2019 Dec; 26(1):1-11. PubMed ID: 31928356 [TBL] [Abstract][Full Text] [Related]
25. A small molecule nanodrug consisting of pH-sensitive ortho ester-dasatinib conjugate for cancer therapy. Gao J; Qiao Z; Liu S; Xu J; Wang S; Yang X; Wang X; Tang R Eur J Pharm Biopharm; 2021 Jun; 163():188-197. PubMed ID: 33864903 [TBL] [Abstract][Full Text] [Related]
26. Nanomicelles based on a boronate ester-linked diblock copolymer as the carrier of doxorubicin with enhanced cellular uptake. Xu Y; Lu Y; Wang L; Lu W; Huang J; Muir B; Yu J Colloids Surf B Biointerfaces; 2016 May; 141():318-326. PubMed ID: 26874117 [TBL] [Abstract][Full Text] [Related]
27. Smart pH/Redox Dual-Responsive Nanogels for On-Demand Intracellular Anticancer Drug Release. Yang H; Wang Q; Huang S; Xiao A; Li F; Gan L; Yang X ACS Appl Mater Interfaces; 2016 Mar; 8(12):7729-38. PubMed ID: 26960600 [TBL] [Abstract][Full Text] [Related]
28. Hybrid nanoparticles based on ortho ester-modified pluronic L61 and chitosan for efficient doxorubicin delivery. Xu X; Xue Y; Fang Q; Qiao Z; Liu S; Wang X; Tang R Int J Biol Macromol; 2021 Jul; 183():1596-1606. PubMed ID: 34022312 [TBL] [Abstract][Full Text] [Related]
29. Bile acid-conjugated chondroitin sulfate A-based nanoparticles for tumor-targeted anticancer drug delivery. Lee JY; Chung SJ; Cho HJ; Kim DD Eur J Pharm Biopharm; 2015 Aug; 94():532-41. PubMed ID: 26149228 [TBL] [Abstract][Full Text] [Related]
30. Insight into the role of dual-ligand modification in low molecular weight heparin based nanocarrier for targeted delivery of doxorubicin. Du H; Liu M; Yu A; Ji J; Zhai G Int J Pharm; 2017 May; 523(1):427-438. PubMed ID: 28359815 [TBL] [Abstract][Full Text] [Related]
31. Reductively degradable α-amino acid-based poly(ester amide)-graft-galactose copolymers: facile synthesis, self-assembly, and hepatoma-targeting doxorubicin delivery. Lv J; Sun H; Zou Y; Meng F; Dias AA; Hendriks M; Feijen J; Zhong Z Biomater Sci; 2015 Jul; 3(7):1134-46. PubMed ID: 26221946 [TBL] [Abstract][Full Text] [Related]
32. Synthesis and Characterization of Dual-Sensitive Fluorescent Nanogels for Enhancing Drug Delivery and Tracking Intracellular Drug Delivery. Wu SY; Debele TA; Kao YC; Tsai HC Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28534813 [TBL] [Abstract][Full Text] [Related]
33. Stepwise pH/reduction-responsive polymeric conjugates for enhanced drug delivery to tumor. Yang S; Wang Y; Ren Z; Chen M; Chen W; Zhang X Mater Sci Eng C Mater Biol Appl; 2018 Jan; 82():234-243. PubMed ID: 29025653 [TBL] [Abstract][Full Text] [Related]
34. Galactose-functionalized multi-responsive nanogels for hepatoma-targeted drug delivery. Lou S; Gao S; Wang W; Zhang M; Zhang J; Wang C; Li C; Kong D; Zhao Q Nanoscale; 2015 Feb; 7(7):3137-46. PubMed ID: 25613320 [TBL] [Abstract][Full Text] [Related]
35. Facile preparation of core cross-linked nanomicelles based on graft copolymers with pH responsivity and reduction sensitivity for doxorubicin delivery. Chen T; Xiao Y; Lu W; Liu S; Gan L; Yu J; Huang J Colloids Surf B Biointerfaces; 2018 Jan; 161():606-613. PubMed ID: 29156337 [TBL] [Abstract][Full Text] [Related]
36. Charge-conversional and reduction-sensitive poly(vinyl alcohol) nanogels for enhanced cell uptake and efficient intracellular doxorubicin release. Chen W; Achazi K; Schade B; Haag R J Control Release; 2015 May; 205():15-24. PubMed ID: 25445693 [TBL] [Abstract][Full Text] [Related]
37. Hydrophobicity-Adaptive Nanogels for Programmed Anticancer Drug Delivery. Yang H; Wang Q; Li Z; Li F; Wu D; Fan M; Zheng A; Huang B; Gan L; Zhao Y; Yang X Nano Lett; 2018 Dec; 18(12):7909-7918. PubMed ID: 30450914 [TBL] [Abstract][Full Text] [Related]
38. Multifunctional nanogel engineering with redox-responsive and AIEgen features for the targeted delivery of doxorubicin hydrochloride with enhanced antitumor efficiency and real-time intracellular imaging. Ma Y; Zhou H; Hu F; Pei Z; Xu Y; Shuai Q Artif Cells Nanomed Biotechnol; 2018; 46(sup3):S900-S910. PubMed ID: 30371105 [TBL] [Abstract][Full Text] [Related]
39. Targeted Smart pH and Thermoresponsive N,O-Carboxymethyl Chitosan Conjugated Nanogels for Enhanced Therapeutic Efficacy of Doxorubicin in MCF-7 Breast Cancer Cells. Verma NK; Purohit MP; Equbal D; Dhiman N; Singh A; Kar AK; Shankar J; Tehlan S; Patnaik S Bioconjug Chem; 2016 Nov; 27(11):2605-2619. PubMed ID: 27643823 [TBL] [Abstract][Full Text] [Related]
40. Biodegradable phosphorylcholine-based zwitterionic polymer nanogels with smart charge-conversion ability for efficient inhibition of tumor cells. Peng S; Men Y; Xie R; Tian Y; Yang W J Colloid Interface Sci; 2019 Mar; 539():19-29. PubMed ID: 30572286 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]